Quanterix (QTRX)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrume...
- Open
- 2.580
- High
- 2.695
- Low
- 2.540
- Prev. Close
- 2.580
- Volume
- 274.59K
- Turnover
- 728.94K
- Avg Price
- 2.655
- Bid/Ask Ratio
- --
- Amplitude
- 6.01%
- 52wk High
- 8.770
- Volume Ratio
- 0.64
- Turnover Ratio
- 0.72%
Quanterix Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$3.0011.52%
Forecast & RatingHold
3analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 19 at 10:38 AM
Quanterix files Form 3 for Chief Commercial Officer James Edward Gute Jr
- Motley Fool · Aug 17 at 04:11 PM
Quanterix (QTRX) Q2 2026 Earnings Call Transcript
- Market Beat · Aug 16 at 06:02 PM
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test
- benzinga_article · Aug 14 at 09:06 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- PUBT · Aug 14 at 08:04 PM
Quanterix director William P. Donnelly reports purchase of USD 286,709 in common shares
- Quartr · Aug 12 at 06:25 PM
QTRX: Diagnostics and clinical trials growth, new leadership, and synergy gains drive optimism for 2024
